Healthequity Inc (HQY) Forecasted to Earn Q4 2018 Earnings of $0.06 Per Share

Healthequity Inc (NASDAQ:HQY) – Research analysts at KeyCorp cut their Q4 2018 earnings estimates for shares of Healthequity in a note issued to investors on Tuesday. KeyCorp analyst D. Hooker now forecasts that the company will post earnings of $0.06 per share for the quarter, down from their prior estimate of $0.10. KeyCorp also issued estimates for Healthequity’s FY2019 earnings at $0.68 EPS.

Several other equities research analysts have also recently commented on the stock. BidaskClub cut shares of Healthequity from a “hold” rating to a “sell” rating in a research report on Thursday. Cantor Fitzgerald reissued a “buy” rating and set a $56.00 price target on shares of Healthequity in a research report on Tuesday, December 5th. Chardan Capital boosted their price target on shares of Healthequity from $58.00 to $62.00 and gave the stock a “buy” rating in a research report on Wednesday. Zacks Investment Research cut shares of Healthequity from a “buy” rating to a “hold” rating in a research report on Wednesday, November 15th. Finally, Robert W. Baird reissued a “hold” rating on shares of Healthequity in a research report on Thursday, September 21st. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and eight have issued a buy rating to the company. The company has an average rating of “Buy” and an average target price of $58.33.

Shares of Healthequity (HQY) opened at $45.72 on Friday. The company has a market cap of $2,773.97, a price-to-earnings ratio of 65.31, a P/E/G ratio of 1.99 and a beta of 1.74. Healthequity has a 52-week low of $37.62 and a 52-week high of $55.31.

Healthequity (NASDAQ:HQY) last posted its quarterly earnings data on Tuesday, December 5th. The company reported $0.17 EPS for the quarter, beating the consensus estimate of $0.13 by $0.04. The business had revenue of $56.80 million for the quarter, compared to analysts’ expectations of $55.27 million. Healthequity had a net margin of 21.08% and a return on equity of 14.47%. The firm’s revenue was up 31.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.10 EPS.

Several institutional investors have recently modified their holdings of HQY. Teachers Advisors LLC lifted its holdings in shares of Healthequity by 6.0% during the 1st quarter. Teachers Advisors LLC now owns 79,893 shares of the company’s stock worth $3,391,000 after acquiring an additional 4,542 shares during the period. Dimensional Fund Advisors LP lifted its holdings in shares of Healthequity by 38.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 377,919 shares of the company’s stock worth $16,042,000 after acquiring an additional 104,960 shares during the period. Renaissance Technologies LLC bought a new stake in shares of Healthequity during the 1st quarter worth approximately $1,426,000. Creative Planning lifted its holdings in shares of Healthequity by 94.4% during the 2nd quarter. Creative Planning now owns 3,274 shares of the company’s stock worth $163,000 after acquiring an additional 1,590 shares during the period. Finally, Aperio Group LLC lifted its holdings in shares of Healthequity by 28.2% during the 2nd quarter. Aperio Group LLC now owns 12,773 shares of the company’s stock worth $636,000 after acquiring an additional 2,806 shares during the period. 98.60% of the stock is owned by institutional investors.

In other Healthequity news, VP Darcy G. Mott sold 9,500 shares of the stock in a transaction that occurred on Wednesday, September 20th. The shares were sold at an average price of $46.79, for a total transaction of $444,505.00. Following the transaction, the vice president now owns 87,500 shares in the company, valued at approximately $4,094,125. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Frank Medici sold 700 shares of the stock in a transaction that occurred on Wednesday, November 15th. The stock was sold at an average price of $51.05, for a total transaction of $35,735.00. Following the transaction, the director now owns 6,381 shares in the company, valued at approximately $325,750.05. The disclosure for this sale can be found here. Insiders have sold a total of 1,743,212 shares of company stock worth $91,145,351 over the last 90 days. 29.00% of the stock is owned by company insiders.

COPYRIGHT VIOLATION WARNING: This article was first published by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this article on another publication, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this article can be viewed at https://sportsperspectives.com/2017/12/10/healthequity-inc-hqy-forecasted-to-earn-q4-2018-earnings-of-0-06-per-share.html.

About Healthequity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Earnings History and Estimates for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply